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Abstract  
In Latin America, cardiovascular disease (CVD) mortality rates will increase by an estimated 145% from 
1990 to 2020. Several challenges related to social strains, inadequate public health infrastructure, and 
underfinanced healthcare systems make cardiometabolic conditions and non-communicable diseases 
(NCDs) difficult to prevent and control. On the other hand, the region has high mobile phone coverage, 
making mobile health (mHealth) particularly attractive to complement and improve strategies toward 
prevention and control of these conditions in low- and middle-income countries. In this article, we 
describe the experiences of three Centers of Excellence for prevention and control of NCDs sponsored by 
the National Heart, Lung, and Blood Institute with mHealth interventions to address cardiometabolic 
conditions and other NCDs in Argentina, Guatemala, and Peru. The nine studies described involved the 
design and implementation of complex interventions targeting providers, patients and the public. The 
rationale, design of the interventions, and evaluation of processes and outcomes of each of these studies 
are described, together with barriers and enabling factors associated with their implementation.  
 
Abbreviations and Acronyms: CVD (cardiovascular disease), NCDs (non-communicable diseases), 
mHealth (mobile health), CHD (coronary heart disease), HTN ( hypertension or hypertensive), LMICs 
(low-and middle-income countries), BP (blood pressure), SMS (short text message system), T2D (type 2 
diabetes), NHLBI (United States National Heart, Lung, and Blood Institute), UHG (United Health 
Group), COEs (centers of excellence), CESCAS (South American Center of Excellence for 
Cardiovascular Health), IECS (Institute for Clinical Effectiveness and Health Policy), CIIPEC (Research 
Centre for the Prevention of Chronic Diseases), INCAP (Institute of Nutrition of Central America and 
Panama), CRONICAS (Center of Excellence in Chronic Diseases at Universidad Peruana Cayetano 
Heredia), ICT (information and communication technology), RCT (randomized controlled trial), PCCs 
(primary care clinics), CHWs (community health workers), apps (applications), mCDSS (mobile clinical 
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decision support system), MIT/CSAIL (Massachusetts Institute of Technology Computer Science and 
Artificial Laboratory), WHO (World Health Organization), UNAN (National Autonomous University of 
Nicaragua), PHCP (primary healthcare providers), CONEMO ( control emocional). 
 
Key words: Latin America; mHealth ; cardiometabolic disease.  
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CARDIOVASCULAR DISEASE BURDEN IN LATIN AMERICA 
Coronary heart disease (CHD) and stroke are the leading causes of death worldwide, accounting for 12.9 
million, or 1 in 4 deaths, in 2010.
1
 Eighty percent of these deaths occur in low- and middle-income 
countries (LMICs), with almost half in people younger than 70 years of age, compared to only 27% 
among corresponding age groups in high-income countries.
2
 In Latin America, from 1990 to 2020, death 
from cardiovascular disease (CVD), including CHD, will increase by an estimated 145% in both women 
and men, compared with increases of 28% in women and 50% in men in developed countries during the 
same period.
3
 The INTERHEART study showed that tobacco use, abnormal lipids, abdominal obesity, 
and high blood pressure (BP)
 4 
could explain the majority of CVD risk for myocardial infarction in the 
Southern Cone. However, responses of most health systems in Latin American countries to CVD and its 
risk factors are poor in addressing the needs of patients with diseases characterized by long duration and 
often slow progression.
5
 In addition, current primary care systems in the region lack preventive programs 
targeting people with high CVD risk.
6 
Latin America faces other problems that make CVD more challenging to prevent and control, including 
socioeconomic factors, inadequate public health infrastructure, lack of preventive programs, 
underfinanced and fragmented healthcare systems, and low levels of community awareness.
7,8 
 
MHEALTH TO ADDRESS CARDIOMETABOLIC DISORDERS AND OTHER Non-
Communicable Diseases (NCDs) IN LATIN AMERICA  
Information and communication technologies represent a potential tool for increasing both the quality and 
quantity of chronic disease management support in the developing world.
9-11
 Overall, Latin America has 
high population coverage by the mobile phone network, with 112% penetration in 2013. Further, due to 
widespread adoption of smartphones and the growth of smartphone connections being highest in the 
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developing world, mobile health (mHealth) interventions are particularly attractive for prevention, 
management and control of cardiometabolic conditions in the region.
12
 Mobile health refers to the use of 
mobile telecommunication and multimedia technologies for healthcare delivery.
13,14
 Mobile phone 
strategies using phone, short message system (SMS), applications for clinical decision support, or 
telemedicine have been shown to improve patient-provider communication, promote behavioral changes, 
and improve chronic disease management and medication adherence in developed countries.
15-17 
With the rapid growth of mobile phone use in LMICs, mHealth is emerging as an opportunity to address 
several healthcare system constraints in these countries, including a scarce and overburdened health care 
workforce, limited financial resources, and an increasing prevalence of chronic diseases. However, 
evidence of the effectiveness of mHealth in relation to its impact and long term effects on prevention and 
control of chronic diseases in LMICs is limited. The majority of studies in LMICs used text messaging 
systems to promote behavior change, but the reported impact of these mHealth interventions was mixed, 
with studies showing only modest benefits for some clinical outcomes.
18,19 
Moreover, one systematic review to address the impact of mHealth on chronic disease outcomes in 
LMICs published by our group reported 9 trials conducted in LMICs, with only one study, focusing on 
diabetes management, conducted in Latin America. Another recent review of mHealth in LMICs reported 
the results of only three studies, two exploratory and one quasi-experimental, addressing CVD and other 
NCDs in the region,
20,21
 which demonstrates that mHealth remains an under-explored topic.  
The United States National Heart, Lung, and Blood Institute and the United Health Group (NHLBI/UHG) 
Chronic Disease Initiative have funded a global network of Centers of Excellence (COEs) to help combat 
chronic diseases in developing countries.
22,23
 These COEs developed infrastructure for research and 
training, and conduct population-based and clinical research to monitor, prevent or control chronic 
diseases. Some of the COEs have also designed and conducted research projects based on mHealth 
interventions to prevent or control chronic conditions with a particular focus on cardiometabolic diseases.  
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In this review, we describe the projects and studies directly linked to developing and/or testing mHealth 
interventions to address cardiometabolic conditions and other NCDs in which three Latin American COEs 
funded by NHLBI either were or are currently involved. These COEs are based in Buenos Aires, 
Argentina (South American Center of Excellence for Cardiovascular Health (CESCAS) at the Institute for 
Clinical Effectiveness and Health Policy (IECS)); Guatemala City, Guatemala (Research Centre for the 
Prevention of Chronic Diseases (CIIPEC) at the Institute of Nutrition of Central America and Panama 
(INCAP)); and Lima, Peru (CRONICAS Center of Excellence in Chronic Diseases at Universidad 
Peruana Cayetano Heredia).
22 
 
MHEALTH PROJECTS TO PREVENT AND CONTROL CARDIOMETABOLIC 
DISORDERS AND OTHER NCDs IN LATIN AMERICA 
The following nine studies are either primarily mHealth projects or have incorporated an mHealth 
component as part of an intervention program to prevent and control cardiometabolic disorders or other 
NCDs. Most of these studies are ongoing and involve the design and implementation of complex 
interventions for changing behaviors of providers and high-risk and/or healthy populations. Following 
Labrique et al. mHealth and information and communication technology (ICT) framework, domains used 
by these projects are: client education and behavior change communication, registries and vital events 
tracking, data collection and reporting, electronic decision support, and provider training and education 
24. 
Mobile functions for these domains include: phone calls, interactive voice responses, text messages, 
clinical decision support applications, data transfer for health record tracking, one-, two - and multi-way 
applications, and mobile telemedicine devices for patient monitoring or diagnosis. 
The studies conducted by these COEs are described below and are also depicted in (Table 1).  
 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
7 
 
Study conducted collaboratively by the three COEs in Argentina, Guatemala, and Peru 
 
A Randomized Controlled Trial (RCT) of a mobile health intervention to improve cardiometabolic profile 
in prehypertensive subjects from low resource urban settings in Latin America 
 
Sponsored by NHLBI, this study aimed to promote healthy lifestyle changes (improvements in diet 
quality and physical activity level) in prehypertensive subjects living in low-income, urban settings in 
Argentina, Guatemala, and Peru, through an mHealth intervention along a one-year of follow-up. A total 
of 637 participants were randomly assigned to receive the intervention (n=316) or usual care (n=321). 
Participants in the intervention arm received counseling on the following target behaviors: reduction of 
dietary sodium intake, reduction of simple sugars and saturated fat intake, increase of fruit and vegetable 
intake, and promotion of physical activity . The intervention was led by nutritionists and had three 
components. First, semi-structured counseling interviews via mobile phones were conducted monthly to 
promote lifestyle modification in accordance with the motivational interviewing technique. Second, after 
the counselor’s call, participants received a weekly SMS tailored to the state of change of the particular 
target behavior addressed by the counselor during the call. Both the content and wording of SMS were 
validated in each of the countries.
25
 Third, we developed a web-based application to support the mHealth 
interventions.
26
 Randomization was stratified by country, with minimization by sex and age groups. 
Primary outcomes were the differences in net changes in systolic and diastolic BP between groups and 
secondary outcomes were changes in body weight, waist circumference, and self-reported target 
behaviors from baseline to 12 months of intervention. Data was analyzed using the intention-to-treat 
approach. Two-hundred and sixty six (84%) participants in the intervention group and 287 (89%) in the 
control group were assessed at 12 months. The intervention did not result in a change in BP compared 
with usual care. However, the study showed a significant net reduction in body weight (-0·66 kg; p=0·04) 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
8 
 
and intake of high-fat and high-sugar foods (-0∙75; p=0∙008) in the intervention group compared with the 
control group. Interestingly, participants in the intervention group who received more than 75% of the 
calls (nine or more calls) had a much higher reduction of their body weight as well as greater 
improvement in some eating behaviors.
27 
 
Studies conducted in Argentina: South American Center of Excellence for Cardiovascular Health, 
(CESCAS), Institute for Clinical Effectiveness and Health Policy. 
 
A comprehensive approach to hypertension prevention and control in low-resource settings in Argentina 
 
Hypertension (HTN) is a public health challenge because of its high prevalence and concomitant increase 
in CVD risk.
28
 Approximately 80% of the attributable burden of HTN occurs in LMICs.
29
 According to 
the recent CESCAS I study, a large-scale, population-based cohort study conducted in 4 cities of the 
Southern Cone and led by IECS, the prevalence of hypertension in the adult population aged 35 to 74 
years was 43.3%. Overall, 62.2% of  HTN patients were aware of their diagnosis, 47.7% were undergoing 
drug treatment, and only 21.5% had achieved BP control.
30 
 
This study is an ongoing cluster RCT, sponsored by NHLBI, in 18 primary care clinics (PCCs) of the 
Argentinian public health network, which has already enrolled almost 2,000 uninsured patients with 
uncontrolled HTN and their families. The aim of this study is to test an 18-month complex intervention 
designed to reduce BP and improve HTN control.
31
 This intervention includes: 1) periodic home visits 
driven by community health workers (CHWs) for education and counseling to HTN persons and their 
families; 2) education, audit, and feed-back to primary care physicians on HTN management; and 3) 
customized SMS for HTN patients and their families, as boosters to complement the educational sessions 
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provided by CHWs. SMS are being sent out weekly to intervention participants to promote lifestyle 
changes, reinforce adherence to antihypertensive medication and promote follow-up visits to the primary 
care doctor at PCCs. Additionally, a process evaluation is being conducted to assess whether the desired 
interventions are adopted by participants and healthcare providers and the extent to which they are 
translated into better outcomes (Table 1).  
 
An educational approach to improving physicians’ effectiveness in the detection, treatment, and control 
of hypercholesterolemia and high CVD risk in low-resource settings in Argentina 
 
Despite the existence of clinical practice guidelines and free access to drug treatment for 
hypercholesterolemia in PCCs in Argentina, uninsured patients with high CVD risk still do not receive 
adequate care and huge gaps in awareness, treatment and control are observed. In Argentina, CVD 
represents 34.2% of deaths and 12.6% of years of potential life lost.
32
 According to CESCAS I study, the 
prevalence of dyslipidemia among adults aged 35-74 years in the Southern Cone is 58.4%.
33
 Multiple 
barriers to the appropriate management of hypercholesterolemia at the point of care can be identified, 
including physicians’ competing demands, lack of adherence to clinical practice guidelines, lack of 
access, medication costs, and patient reluctance to take medication.
34,35 Interventions that have been 
effective in dealing with barriers related to clinical practice are educational interventions (academic 
detailing, educational outreach visits, audit and feed-back) and clinical decision support systems 
(CDSS).
36-38
 Mobile phones are recognized as a viable platform for improving health care delivery in low-
resource settings in developed countries.
20,39
 With the rapid uptake and use of smartphone technology, 
there has been a surge in the development of mobile applications (apps) for health. Clinical decision 
support systems in mHealth apps (mCDSS) for patient care can improve clinical decision making.
40,41
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This ongoing study, sponsored by the International Atherosclerotic Society and Pfizer Foundation, aims 
to evaluate whether a multi-component intervention, lasting 12 months, that incorporates academic 
detailing through outreach visits and an mCDSS for primary care physicians, as well as educational SMS 
and reminders for patients, improves the detection, treatment and control of hypercholesterolemia among 
patients with moderate-high CVD risk in Argentina. This study is a cluster RCT recruiting 350 patients 
from 10 public PCCs.
42
 The mCDSSs on the physicians’ smartphones are used to provide evidence-based 
and guideline-driven decision aids to improve patient management. This app uses the open-source Sana 
mobile telehealth platform, a highly open telemedicine framework developed by the Massachusetts 
Institute of Technology Computer Science and Artificial Laboratory (MIT/CSAIL).
43,44
 Participants in the 
intervention group receive SMS for life-style modification and to improve treatment adherence, as well as 
prompts and reminders for clinic appointments. The main primary outcome measure is the net change of 
the LDL-c values between baseline and 12 months. As part of the process evaluation, engagement and 
usability of the mCDSS as well as adherence to clinical practice guidelines will be assessed to explore 
whether the mHealth component is adopted by physicians (Table 1).  
 
Strengthening diabetes care for underserved populations in the province of Corrientes, Argentina 
 
High rates of physical inactivity, unhealthy diets, overweight and obesity, each of which are related to the 
epidemiological and nutritional transition, are leading to an increased prevalence of  type 2 diabetes 
(T2D)  in developing countries.
45
 It is estimated that by 2030, the number of people with T2D in South 
and Central America will increase from 25 to 39.3 million.
46
 In this epidemic, T2D is over-represented 
among lower socioeconomic groups.
47
 According to the National Risk Factor Survey, the prevalence of 
T2D in Argentina increased from 8.5% to 9.8 % from 2005-2013, reaching epidemic proportions and 
representing a significant public health problem.
48,49
 Creative solutions are necessary to address the 
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escalating healthcare demands of chronic conditions, especially in low resource settings where public 
primary care infrastructure is limited and overwhelmed.
50,51 
This study is sponsored by the World Diabetes Foundation and will evaluate whether a multifaceted 
intervention over a 12 month period, incorporating primary care training in diabetes management and the 
implementation of an ICT system, improves T2D quality of care at PCCs in low resource settings in the 
province of Corrientes, Argentina, a poor northeastern province in the Argentinean Mesopotamia. The 
ICT system uses the Sana mobile telehealth platform and is comprised of a T2D registry and a mCDSS 
for health care providers in an mHealth app.
43, 44
 The app is installed on a tablet and is used to identify 
T2D patients and to track and monitor T2D care. The recorded information is used as input to generate 
tailored educational SMS and reminders to improve adherence, treatment, and follow-up of T2D patients. 
This study, an uncontrolled before-after quasi experimental study, will enroll 1000 T2D patients in 20 
public PCCs. Process and outcome measures will include T2D quality of care indicators as well as 
clinical outcomes. It will also include a qualitative component to assess acceptability and engagement of 
the ICT system among health care professionals and acceptability and satisfaction with the SMS among 
T2D patients (Table 1).  
 
mHealth interventions to improve access and coverage of uninsured people with high CVD risk in 
Argentina 
 
CVD is a major and growing health problem in LMICs and is also a cause of the widening health 
inequity. Exploring ways to increase screening of persons with high CVD risk in community settings and 
timely referral to PCCs is a significant priority to reduce the CVD burden in Argentina. The Ministry of 
Health of Argentina has created a program to reduce inequities by strengthening the primary care model 
through increased training and technological infrastructure support, and improving control of those 
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uninsured at high CVD risk through the provision of free essential drugs. The program uses the WHO 
package for the assessment and management of cardiovascular risk in low-resource settings.
52
 
Interventions delivered by the program include: 1) identification and enrollment of uninsured populations 
in the catchment area served by public PCCs; 2) CVD risk stratification and classification of subjects by 
health care professionals; 3) treatment with generic drugs as needed for subjects with HTN, T2D, or 
moderate-high CVD risk (≥10%); and, 4) regular follow-up in patients with moderate and high CVD risk. 
The program operates through financial incentives to providers to increase the enrollment, screening and 
follow-up of those uninsured at high risk for CVD. Unfortunately, uptake and retention at the PCCs are 
dismally low; less than a third of moderate-high CVD risk subjects eventually attend the PCCs—only 
20% within 2 months. Furthermore, fewer than 15% of all subjects classified as having ≥10% CVD risk 
actually receive more than one consultation with the primary care doctor in the following year of follow-
up (REDES Program-personal communication).  
The study was designed as a cluster RCT, sponsored by the Fogarty International Center/ National 
Institute of Health, to determine whether the use of mHealth tools by CHWs (CVD risk calculator  and a 
PCCs scheduling system) increase the number of persons with high CVD risk who are stratified, referred, 
and appropriately followed-up at the public PCCs in low resource settings. It will also evaluate the cost-
effectiveness of the proposed intervention. Eight PCCs within the public network will be randomized to 
either apply the integrated mHealth tool or use the usual paper-based CVD screening charts. The study 
will enroll 740 adults with public coverage and a 10-year CVD risk ≥ 10%.  
We will develop an mHealth tool for CHWs that integrates an app to calculate CVD risk and a system 
synchronized with the PCC’s scheduling system in the mobile phone. The app will be built using the Sana 
mobile telehealth platform and will allow CHWs to make appointments for the identified high-risk 
individuals at the time of screening.
43,44
 Participants will receive SMS messaging as reminders for the first 
appointments and follow-up visits, as well as educational messages for lifestyle modification.  
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The primary outcomes will be the proportion of participants with a 10-year CVD risk ≥ 10% who attend 
the baseline clinical appointment and the proportion of these participants who attend the scheduled 
follow-up visits to their PCCs within 4 months of the baseline visit (Table 1). 
 
Study conducted in Guatemala –INCAP Research Center for the Prevention of Chronic Diseases 
(CIIPEC), Institute of Nutrition of Central America and Panama (INCAP). 
 
Feasibility and acceptability of an intervention to promote the sale of "healthy eating" in a university 
campus in Managua, Nicaragua 
 
Health Promoting Universities conduct health education and health promotion for students and staff, 
integrating health into the culture, processes, and policies of the university.
53
 A previous study in the 
National Autonomous University of Nicaragua (UNAN) at the Managua campus showed that only 8% of 
university canteens sell healthy food.
54 
The aim of this study, which is sponsored by the International Development Research Centre, is to 
evaluate the feasibility and acceptability of a 10-week, multi-component intervention that includes: 
training of owners and employees of university canteens in healthy cooking; implementation of flyers to 
increase the demand and supply of healthy products; and an e-health intervention to promote the sale of 
"healthy food" at the university campus of UNAN-Managua.
55
 The e-health strategy incorporates a 
website, social media, and a mobile application for android-running cell phones called "Yo como 
saludable" (I eat healthy). In this application, users will find weekly menus offered by the selected 
establishments, including healthy dishes of the week, side dishes, and prices. The app will also offer 
weekly tips to promote a healthy and balanced diet and the user will also be able to share menus through 
social media and email. This application was created by UNAN staff and is available for free download in 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
14 
 
Play Store. In addition, all of this information can be viewed on a website also created by UNAN staff. 
The study will evaluate six university canteens and 300 users (students and university staff) using a before 
and after design to assess the number of healthy dishes offered and sold per week and users’ food 
preferences. Other outcome variables will be the number of students/staff who downloaded the app and 
checked the website, and the mean number of interactions among users of the app (Table 1). Results from 
this study are expected to be published at the end of 2016. 
 
Studies conducted in Peru – CRONICAS Center of Excellence in Chronic Diseases, Universidad 
Peruana Cayetano Heredia. 
 
Allillanchu. Integration of mental health into primary health care services in Lima, Peru 
 
Neuropsychiatric disorders affect one in every five Peruvians and are the leading cause of disease burden 
in the country.
56,57
 In Lima, Peru’s capital city, almost 20% of the population has suffered depression at 
one point in their lives.
58
 Depression among primary healthcare users can be very high—up to 40% of 
pregnant women,
59,60
 52% of patients with tuberculosis,
61
 and 30% of patients with T2D.
62
 Depression is 
associated with reduced treatment adherence, poorer prognosis, greater disability, and higher mortality 
among sufferers of non-psychiatric diseases.
63
 Despite its high prevalence and impact on patient 
adherence, depression is largely underdiagnosed and undertreated.
64,65
 This context offers an opportunity 
to address strategies oriented towards the integration of health services.
66 
Allillanchu is a greeting term in Quechua, which means “how are you, how are you feeling?” The 
Allillanchu project, sponsored by Grand Challenges Canada’s Global Mental Health initiative, aims to 
promote the early detection, opportune referral, and access to treatment for people with common mental 
disorders who are regular users of PCCs: pregnant women and patients with T2D, HTN, tuberculosis and 
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HIV/AIDS. To achieve its goal, the project will design, develop, and test an mHealth strategy that 
comprises (1) a mobile app installed in a tablet for the screening of common mental disorders during the 
regular consultations of primary healthcare providers (PHCP) and (2) the use of SMS as a reminder and 
motivational tool for patients identified with the screening app to seek mental health care.  
This pragmatic strategy is tested during 2 months with 20 PHCP from 5 public PCCs in Lima, Peru, using 
a mixed-methods design that includes both qualitative and quantitative methods.
67
 The outcomes to be 
measured include: number of primary health care providers (PHCP) trained, number of PHCP who pass 
the training evaluation, number of PHCP who implement screening in their daily service routines, number 
of screened patients, proportion of referred patients who seek mental health care, proportion of referred 
patients that access mental health care, and proportion of PHCP willing to include the mHealth package in 
their daily practice. The intervention is preceded by a qualitative study with service users, primary health 
care providers and mental health specialists, and includes a detailed process evaluation of the 
implementation (Table 1). 
 
Implementation of foot thermometry and SMS to prevent diabetic foot ulcer  
 
Diabetic foot neuropathy is one of the most important complications of diabetes. Its early diagnosis and 
treatment can prevent foot ulcers and amputation.
68
 The use of thermometry is a promising modality to 
prevent diabetic foot ulcers.
69,70
 However, patient compliance with temperature self-monitoring is a 
concern because it is difficult to get into a consistent routine of daily monitoring.
71 
This study is a 12-month controlled trial, sponsored by the Fogarty International Center/NIH,  that will 
assess whether the use of SMS and voice messages can remind and motivate diabetic patients to perform 
daily temperature measurements of their feet in order to prevent diabetic foot ulcers.  
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A total of 172 patients with type 2 diabetes mellitus at high risk of ulceration, recruited in two public 
hospitals in Lima, Peru will be randomly assigned to the control or intervention groups. Both arms will 
receive education and an electronic foot thermometer, but the intervention group will also receive a year 
of weekly SMS and voice messages to remind and encourage temperature daily measurements. 
The main primary outcome will be foot ulceration, as defined by the American Diabetes Association, at 
any point during the 12-month study (Table 1). 
 
 Latin American treatment & innovation network in mental health (Latin-MH)  
 
Worldwide, mental, neurological, and substance-use disorders account for nine out of the 20 leading 
causes of years lived with disability and 10% of the global burden of disease.
72
 Indeed, by 2030, 
depression is projected to be the world-leading cause of burden of disease.
73
 Depression is strongly 
associated with diabetes and heart disease, non-adherence to medical treatments, and progression of 
disability across a range of chronic conditions.
74,75
 Notwithstanding the public health impact of 
depression, it often goes unrecognized and untreated.
76-82 
LATIN-MH is one of the 5 hubs awarded by the US-National Institute of Mental Health to increase 
research capacity and reduce the mental illness treatment gap in resource-poor settings.
83
 The research 
component of the LATIN-MH hub comprises two studies: a cluster RCT that will be conducted in Sao 
Paulo, Brazil, and a RCT in Lima, Peru, to assess the effectiveness of CONEMO (Control Emocional), a 
6-week low-intensity psycho-educational intervention delivered via smartphones and supported by 
auxiliary nurses. The aim of CONEMO, based on the principles of behavioral activation model, is to 
reduce depressive symptoms among individuals with T2D and/or HTN who attend to public health care 
centers in low-resource settings. In Sao Paulo, 20 public PCCs will be randomized to the intervention or 
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control groups and 851 participants will be included. In Lima, 421 individuals will be randomly assigned 
to one of the two arms after their recruitment by PCCs of the public health system. Adults with a PHQ-9 
score ≥ 10 and a previous diagnosis of hypertension and/or diabetes will be recruited to be part of the 
studies. The primary outcome will be the proportion of participants whose depressive symptoms have 
decreased (PHQ-9<10) at 3 months after enrollment into the trial. Each RCT will be preceded by a pilot 
study. The project includes process and cost-effectiveness evaluations of the intervention in both 
countries (Table 1).  
 
IMPLICATIONS AND FURTHER RESEARCH  
Implementing mHealth interventions in LMICs is a challenge, particularly when these interventions are 
tested in low-income settings and within a research framework.
84
 The barriers to the implementation of 
research studies in poor settings include the complexity of interventions, multiple components acting on 
providers, patients, the community, and clinical settings; a limited capacity of local human resources to 
adopt research methods in a context of a poor evaluative culture; a lack of leadership and management 
skills at the local level; weak health systems; and a complex social, cultural, and political context.
41
 There 
are several limitations specifically regarding technology use and project implementation, which include 
but are not limited to: technological illiteracy, health workers’ resistance to new technology, different 
patterns of cell phone usage among underserved populations, shared or lack of mobile phones for personal 
use, lost or stolen phones, limited connectivity, need of smartphone application updates and lack of 
standardized data security protocols for the region to assure interoperability and to maximize the full 
capabilities of mobile devices.
85 
 
However, to sort out these “barriers,” we have identified some specific enabling factors related to 
mHealth interventions that have proved to extend the following benefits in poor settings: 
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1) Use of open source software like Sana with intuitive user interfaces to enhance usage and adoption 
among health care professionals; 2) Frameworks that allow data collection in poor or intermittent 
connectivity settings and that are compatible with a low grade software; 3) building local capacity to 
enhance the perceived skills and motivation of the health personnel as an avenue to improve technological 
literacy and reduce resistance to new technology; 4) include participants who have a cell phone for 
personal use to assure that they will receive a full dose of intervention; 5) lending, providing, or 
incentivizing the ownership of smartphones for health care professionals participating in studies that 
include data collection; 6) training and periodic retraining of study personnel to avoid departure from the 
protocol and introduce  rigorous methods of assessment derived from clinical research, and create an 
evaluative environment; 7) close monitoring of field work, both on-site and through telephone and e-mail 
follow-up, is important for auditing, feedback, and, perhaps more important, for supporting the local 
research team in dealing with the many hurdles that usually arise during implementation; 8) flexibility to 
respond to changes in local conditions that can affect the study, such as competing activities at the health 
care centers , lack of personnel, and seasonal jobs; 9) using social media to engage health care 
professionals or study participants that are involved in the studies; 10) inclusion of process evaluation and 
qualitative information to assist with interpretation of the outcome results as participating health care 
professionals explore the implementation, barriers and enablers, reception, and setting of interventions; 
and 11) design of a data-management workflow to allow efficient and timely data and quality-control 
measures.  
The likelihood of success might be increased by strong leadership and governance and by the active 
engagement of a broad range of implementers and key stakeholders, including local community 
organizations and through the collaboration with operators to ensure technical support and scaling-up, and 
to reduce the costs to drive mHealth demands and innovation. 
In LMICs, pilot projects have demonstrated conceptually how mHealth can alleviate specific health 
system constraints; however, we still need robust evidence to consider mHealth alongside essential health 
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interventions and guidance about which mHealth interventions should be considered to achieve broader 
health system goals.
86 
Unfortunately, in Latin America there is limited evidence on the effects of mHealth within healthcare 
systems. To our knowledge, there is only one RCT, conducted in Argentina, Guatemala and Peru by our 
COEs, and recently published, evaluating an mHealth intervention to promote healthier behaviors in 
individuals at higher cardio-metabolic risk in Latin America. As mentioned above our one-year 
intervention did not result in a change in BP, but it produced a reduction in body weight, as well as an 
improvement in diet quality.
27 
 
In conclusion, mHealth, is leveraging an increasingly expanded mobile phone network and looks to be a 
promising technology in Latin America, which usually deals with weak and fragmented health care 
systems. However, many questions regarding its effectiveness remain unanswered today such as: which 
domains and mobile functions (voice, SMS, video, apps, software) are most effective  to prevent and 
control these conditions, whether the effectiveness of interventions is determined by socio-demographic 
characteristics of populations, user charges,  culture or context, local health care systems, and  which are 
the implementation hurdles related to the uptake, ownership, dissemination, and scaling up of these 
interventions if they prove to be successful.  
In this sense, in the majority of studies, selected design will provide strong and unbiased estimations of 
the impact of mHealth interventions. In addition, proposed mHealth interventions have been integrated 
into health programs, services, and the community, and formative research and process evaluations will 
help to identify enablers and barriers to the implementation, how integration works and future uptake.  
This new technology has considerable potential and these ongoing studies will add evidence to determine 
if mHealth is effective to prevent and control cardiometabolic diseases and other NCDs and how to 
integrate these interventions in the Latin America's segmented health systems.  
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Table 1. Summary of the studies conducted in the three Latin American COEs 
Center of 
Excellenc
e 
Study Study 
Design 
Target 
Populatio
n and 
Sample 
size 
Durat
ion 
mHealth  
Interventi
on 
compone
nt 
Other 
Intervention 
components 
Outcome 
Measures 
Argentina 
(CESCA
S), 
Guatemal
a 
(CIIPEC)
, Perú 
(CRONI
CAS) 
A Randomized 
Controlled 
Trial of a 
mobile health 
intervention to 
improve 
cardiometaboli
c profile in 
prehypertensiv
e subjects 
from low 
resource urban 
settings in 
Latin America 
 
Individu
al RCT 
637 pre-
hypertensi
ve 
individual
s 
randomiz
ed: 316 
allocated 
to the 
interventi
on and 
321 to the 
control 
arm. 
12  12 
month
s 
1) 
Monthly 
motivatio
nal 
counselin
g calls to 
their 
mobiles 
along one 
year. 
2) 
Weekly 
boosters 
of 
individua
lized 
short 
 1) Mean 
difference 
of change in 
systolic 
(SBP) and 
diastolic 
(DBP) 
blood 
pressure.  
2) Other 
secondary 
outcomes: 
changes in 
body 
weight, 
waist 
circumferen
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message 
services 
(SMS) 
targeted 
to 
improve
ment of 
diet 
quality 
and 
physical 
activity, 
or usual 
care. 
ce, and self-
reported 
target 
behaviors 
between the 
intervention 
and control 
arm from 
baseline to 
12 months. 
Argentina 
(CESCA
S),  
Institute 
for 
Clinical 
Effective
ness and 
Health 
Policy  
A 
Comprehensiv
e Approach to 
Hypertension 
Prevention and 
Control in 
Low-resource 
settings in 
Argentina 
 
Cluster 
RCT 
 
18 PCCs 
and 1950 
uninsured 
hypertensi
ve adults 
and their 
families 
18 
mont
hs 
1) 
Educatio
nal SMS 
and 
reminders 
to 
promote 
healthy 
lifestyle 
habits 
1) Primary 
care 
physicians 
training on 
HTN 
management. 
2) Physician 
Audit and 
feed-back. 
3) Home visits 
1) Net 
change in 
the SBP and 
DBP value 
at baseline, 
6, 12 and 18 
months of 
follow-up. 
2) 
Proportion 
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and 
adherenc
e to HTN 
drugs and 
doctor 
appointm
ents at 
the PCCs. 
driven by 
CHWs to 
hypertensive 
individuals 
and their 
families to 
promote 
lifestyle 
modification, 
and adherence 
to HTN 
medication 
and follow-up 
at PCCs. 
 
 
of HTN 
control at 
baseline, 6, 
12 and 18 
months of 
follow-up. 
3) Self-
reported 
medication 
adherence 
among 
hypertensiv
e patients at 
baseline, 6, 
12 and 18 
months of 
follow-up. 
4) Net 
change in 
body weight 
and waist 
circumferen
ce at 
baseline, 6, 
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12 and 18 
months of 
follow-up. 
5) Cost-
effectivenes
s and 
process 
evaluation 
outcomes. 
An 
Educational 
Approach to 
Improving 
Physicians’ 
Effectiveness 
in the 
Detection, 
Treatment, and 
Control of 
hypercholester
olemia and 
high CVD risk 
in low-
resource 
Cluster 
RCT 
10 public 
PCCs and 
350 
patients 
with 
moderate-
to-high 
cardiovas
cular risk 
12 
mont
hs 
1) a 
mCDSS 
to guide 
lipid 
managem
ent. 
2) 
Educatio
nal SMS 
and 
reminders 
to 
promote 
adherenc
e to 
1) Primary 
care physician  
training in 
hypercholester
olemia and 
high CVD risk 
management. 
2) Educational 
outreach visits 
to physicians. 
1) Net 
change of 
LDL-c 
values at 
baseline, 6 
and 12 
months of 
follow-up. 
2) Net 
change in 
10-year-
CVD 
Framingha
m risk score 
before and 
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settings in 
Argentina 
 
treatment. after the 
implementat
ion of the 
program at 
baseline, 6 
and 12 
months of 
follow-up. 
3) 
Proportion 
of patients 
with 
moderate-
high CVD 
risk who 
have 
reduced 
30% and 
50% of their 
LDL-C at 
baseline, 6 
and 12 
months of 
follow-up. 
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4) 
Proportion 
of patients 
with high 
CVD risk 
who are on 
statins, and 
are 
receiving an 
appropriate 
dose 
according to 
the CPG at 
baseline, 6 
and 12 
months of 
follow-up. 
Strengthening 
Diabetes Care 
for 
Underserved 
in the province 
of Corrientes, 
Argentina 
Before-
after 
quasi-
experim
ental 
20 PCCs 
and 1000 
diabetic 
patients 
12 
mont
hs 
1) An 
ICT 
system: 
electronic 
diabetes 
registry 
associate
1) Primary 
care team 
training in 
diabetes 
management 
and education.   
1) 
Proportion 
of diabetics 
with an 
annual A1c 
value, eye 
and foot 
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 d with a 
mCDSS 
for health 
care 
professio
nals to 
guide 
diabetes 
care. 
2) 
Educatio
nal SMS 
and 
reminders 
for 
diabetic 
patients. 
exam. 
2) 
Proportion 
of diabetics 
with poor 
metabolic 
control 
(HbA1c˃9
%) at 
baseline, 6 
and 12 
months of 
follow-up. 
2) 
Proportion 
of diabetics 
with HTN 
control 
(BP≤140/90 
mmHg) at 
baseline, 6 
and 12 
months of 
follow-up. 
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mHealth 
Interventions 
to improve 
access and 
coverage of 
uninsured 
people with 
high 
cardiovascular 
risk in 
Argentina 
 
Cluster 
RCT 
8 public 
PCCs and 
350 
patients 
with a 10 
year CVD 
risk ≥ 
10% 
6 
mont
hs 
1) 
mCDSS 
for 
CHWs to 
calculate 
CVD risk 
associate
d with a 
schedulin
g systems 
in a 
mobile 
phone to 
refer and 
make 
clinical 
appointm
ent to 
PCCs in 
patients a 
10 year 
CVD risk 
≥ 10%. 
2) 
 1) 
Proportion 
of 
participants 
with a10 -
year CVD 
risk ≥ 10% 
who  have 
successfully 
completed 
the baseline 
(first) visit 
to a clinic 
out of all 
those 
classified as 
having risk 
>10% 
within the 
prior 6 
weeks in the 
community. 
2) 
Proportion 
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Educatio
nal SMS 
and 
reminders 
for 
participan
ts to 
attend 
appointm
ents. 
of 
participants 
with a10 -
year CVD 
risk ≥ 10% 
who attend 
follow-up 
visits at 
PCCs 
within 4 
months of 
the baseline 
visit. 
3) Cost 
effectivenes
s and 
process 
evaluation 
outcomes. 
 INCAP 
Research 
Center 
for the 
Preventio
Feasibility and 
acceptability 
of an 
intervention to 
promote the 
Quasi-
experim
ental 
(pre-post 
with no-
6 Food 
establish
ments and 
300 users 
(universit
10 
weeks 
1) A 
mobile 
phone 
app and a 
website 
1) Healthy 
cooking 
training for 
staff of 
university 
1) Number 
of 
students/staf
f who 
downloaded  
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n of 
Chronic 
Diseases  
sale of 
"healthy 
eating" in the 
university 
campus Ruben 
Dario National 
Autonomous 
University of 
Nicaragua, 
UNAN-
Managua  
treatmen
t control 
group) 
y students 
and staff) 
that show 
daily 
menus, 
healthy 
dishes, 
prices, 
and 
promote 
healthy 
eating 
through 
education
al tips. 
canteens.  
2) on-site 
advertisement 
strategy and 
through the 
university 
social media 
and website 
the app and 
checked the 
website. 
1) Mean 
number of 
interactions 
among 
users of the 
mHealth 
app. 
2) Number 
of new 
healthy 
dishes 
offered and 
sold per 
week. 
3) Users’ 
food 
preference.   
 
CRONIC
AS, 
Universid
Allillanchu. 
Integration of 
Mental Health 
Quasi-
experim
ental and 
20 PHCP 
of 5 
public 
2 
mont
hs 
1) an app 
installed 
in a tablet 
  
 
1) Number 
PHCP 
trained. 
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ad 
Peruana 
Cayetano 
Heredia 
into Primary 
Health Care 
Services in 
Lima, Peru 
 
 
qualitati
ve study 
PCCs 
Pregnant 
women 
and 
patients 
with 
diabetes, 
hypertensi
on, 
tuberculos
is and 
HIV/AID
S who are 
regular 
users of 5 
public 
PCCs. 
 
for the 
screening 
of 
common 
mental 
disorders 
during 
the 
regular 
consultati
ons of 
PHCP. 
2) Use of 
SMS to 
remind 
and 
motive 
patients 
to seek 
mental 
health 
care. 
2) Number 
of PHCP 
who pass 
the training 
evaluation. 
3) Number 
of PHCP 
who 
implement 
screening in 
their daily 
service 
routines. 
4) Number 
of screened 
patients. 
5) 
Proportion 
of patients 
who seek 
mental 
health care 
after being 
identified 
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and referred 
by a PHCP. 
6) 
Proportion 
of patients 
who access 
mental 
health care 
after being 
identified 
and referred 
by a PHCP. 
7) 
Proportion 
of PHCP 
willing to 
include the 
mHealth 
package in 
their daily 
practice 
after the end 
of the 2-
month 
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intervention 
Implementatio
n of foot 
thermometry 
and SMS to 
prevent 
diabetic foot 
ulcer  
 
RCT 172 
patients 
with type 
2 diabetes 
at high 
risk of 
ulceration 
who 
receive 
care at 2 
public 
hospitals 
 (86 in 
each 
group) 
12 
mont
hs 
1) SMS 
and voice 
messages 
to remind 
and 
promote 
the use of 
the foot 
thermom
eter, 
during 
one year. 
First two 
weeks 
participan
ts will 
receive 
daily 
reminders 
and for 
the 
remainin
g 50 
  
 
1) 
Proportion 
of patients 
with foot 
ulceration 
(at least one 
ulcer) along 
a 1-year 
follow-up. 
2) 
Proportion 
of patients 
who 
adherence 
to daily 
temperature 
measureme
nts (at least 
50% of 
daily 
measureme
nts during a 
1 year 
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weeks, 
patients 
will 
receive 
two 
messages 
per week, 
one SMS 
and one 
voice 
message, 
alternatin
g content. 
period). 
 
Peru 
(Lima) & 
Brazil 
(Sao 
Paulo) 
CRONIC
AS 
Center of 
Excellenc
e in 
Chronic 
Latin America 
Treatment & 
Innovation 
Network in 
Mental Health 
(LATIN-MH) 
Cluster 
RCT & 
RCT 
Adults 
with 
hypertensi
on and/or 
diabetes 
attending 
ambulator
y clinics, 
and who 
present 
depressiv
3 
mont
hs 
1) 
Control 
Emocion
al 
(CONEM
O), a 6 -
week 
low-
intensity 
psycho-
education
 1) 
Proportion 
of 
participants 
whose 
depressive 
symptoms 
have 
“recovered” 
(PHQ-
9<10) at 
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Diseases, 
Universid
ad 
Peruana 
Cayetano 
Heredia 
 
Universit
y of Sao 
Paulo 
Northwes
tern 
Universit
y 
London 
School of 
Hygiene 
and 
Tropical 
Medicine 
 
e 
symptoms 
(PHQ-9 ≥ 
10). 
421 
participan
ts in Peru 
and 20 
PCCs , 
851 
participan
ts in 
Brazil 
(50% in 
each 
arm). 
al 
interventi
on, based 
on 
behaviora
l 
activation 
model, 
delivered 
via 
smartpho
nes 
phones 
assisted 
by an 
auxiliary 
nurse for 
reducing 
depressiv
e 
symptom
s. 
baseline and 
3 months.  
2) 
Depressive 
symptoms 
at baseline 
and 3 
months 
(PHQ-9). 
3) Social 
functioning 
at baseline, 
and 3 
months 
(WHO-
DAS 2.0). 
4) Quality 
of life at 
baseline and 
3 months 
(EQ-5D). 
5) 
Adherence 
to 
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medication 
for diabetes 
and 
hypertensio
n at 
baseline, 
and 3 
months 
(Morisky 
Medication. 
Adherence 
Scale-
MMAS-4) 
6) Level of 
activity at 
baseline and 
3 months 
(Behavioral 
Activation f
or 
Depression 
Scale 
BADS). 
7) Cost- 
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SBP, (systolic blood pressure), DBP (diastolic blood pressure), ICT (Information and Communication  
Technology System), PCCs (Primary Care Clinics), CHWs ( community health workers), mCDSS (A 
clinical decision support systems in a mobile apps), PHCP (Primary Health Care Providers) 
effectivenes
s and 
process 
evaluation 
outcomes.  
